125.91
0.84%
-1.07
After Hours:
125.91
Quest Diagnostics, Inc. stock is currently priced at $125.91, with a 24-hour trading volume of 857.29K.
It has seen a -0.84% decreased in the last 24 hours and a -1.74% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $127.2 pivot point. If it approaches the $125.2 support level, significant changes may occur.
Quest Diagnostics, Inc. Stock (DGX) Financials Data
Quest Diagnostics, Inc. (DGX) Revenue 2024
DGX reported a revenue (TTM) of $9.25 billion for the quarter ending December 31, 2023, a -6.38% decline year-over-year.
Quest Diagnostics, Inc. (DGX) Net Income 2024
DGX net income (TTM) was $854.00 million for the quarter ending December 31, 2023, a -9.73% decrease year-over-year.
Quest Diagnostics, Inc. (DGX) Cash Flow 2024
DGX recorded a free cash flow (TTM) of $864.00 million for the quarter ending December 31, 2023, a -34.25% decrease year-over-year.
Quest Diagnostics, Inc. (DGX) Earnings per Share 2024
DGX earnings per share (TTM) was $7.49 for the quarter ending December 31, 2023, a -5.43% decline year-over-year.
Quest Diagnostics, Inc. Stock (DGX) Latest News
Earnings Preview: Quest Diagnostics (DGX) Q1 Earnings Expected to Decline
Zacks Investment Research
Quest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?
Zacks Investment Research
Myriad Genetics (MYGN) Announces Favorable Research Results
Zacks Investment Research
Quest Diagnostics (DGX) Collaborates With Broad Clinical Labs
Zacks Investment Research
Labcorp (LH) Boost Diagnostics Suite With New Biomarker Test
Zacks Investment Research
Key Takeaways From Quest Diagnostics Analyst Ratings
Benzinga
About Quest Diagnostics, Inc.
Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. The company's Diagnostic Information Services business segment develops and delivers diagnostic testing information and services, such as routine testing, non-routine and advanced clinical testing, gene-based and esoteric testing, anatomic pathology, and other diagnostic information services. This segment offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. Its Diagnostic Solutions segment offers risk assessment services for the life insurance industry; and health information technology solutions for healthcare organizations and clinicians. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Cap:
|
Volume (24h):